Signaling pathways
-
BA7225 RelacatibSummary: Relacatib (SB-462795) is a new, potent, orally active inhibitor of human histones K,L and V. It has been shown to be an effective inhibitor of human histones K,L and V. It has been shown to be an effective inhibitor of human histones K,L and V. - BA7226 RO5461111Summary: RO5461111 is a highly specific, orally effective antagonist.
- BA7227 Z-FF-FMKSummary: Z-FF-FMK is a selective histone-L inhibitor.
- BA7228 Z-Phe-Arg-pNASummary: Substrate for histone L.
- BA7229 Z-FG-NHO-BzOMESummary: Z-FG-NHO-BzOME is a cysteine protease inhibitor.
- BA7230 MIV-247Summary: MIV-247 is a selective tissue protease S inhibitor.
- BA7231 Bz-FVR-AMCSummary: Bz-FVR-AMC is a histone fluorescent substrate.
- BA7232 Z-Phe-Ala-diazomethylketoneSummary: Z-Phe-Ala-diazomethylketone binds directly to Aβ42 monomers and small oligomers.
- BA7233 Ac-VLPE-FMKSummary: Ac-VLPE-FMK is a tetrapeptidyl monofluoromethyl ketone (m-FMK), an and inhibitor.
- BA7234 CKD-519Summary: CKD-519 is a potent and selective inhibitor of cholesteryl ester transfer protein.